ADK and neoplasm: Helena Marcelino et al. tested the effect of two ADK inhibitors on tumor cells in experiments on glioblastoma, and the results suggested that both ITU (25 μM) and ABT702 (15 μM) affected cells proliferation/viability (Marcelino et al., 2021).